INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 124 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $79 | +338.9% | 96,073 | +714.3% | 0.00% | – |
| Q4 2022 | $18 | -100.0% | 11,798 | -83.5% | 0.00% | -100.0% |
| Q3 2022 | $123,000 | -78.6% | 71,417 | -78.6% | 0.00% | -66.7% |
| Q2 2022 | $576,000 | +428.4% | 332,971 | +995.0% | 0.01% | +500.0% |
| Q1 2022 | $109,000 | -61.6% | 30,407 | -46.5% | 0.00% | -50.0% |
| Q4 2021 | $284,000 | -76.8% | 56,821 | -66.7% | 0.00% | -66.7% |
| Q3 2021 | $1,222,000 | +1109.9% | 170,739 | +1464.5% | 0.01% | – |
| Q2 2021 | $101,000 | -70.2% | 10,913 | -70.1% | 0.00% | -100.0% |
| Q1 2021 | $339,000 | -1.2% | 36,482 | -5.9% | 0.00% | 0.0% |
| Q4 2020 | $343,000 | -60.7% | 38,781 | -48.5% | 0.00% | -66.7% |
| Q3 2020 | $873,000 | -8.2% | 75,255 | +113.3% | 0.01% | -25.0% |
| Q2 2020 | $951,000 | +288.2% | 35,283 | +7.2% | 0.01% | +300.0% |
| Q1 2020 | $245,000 | -14.3% | 32,902 | -62.0% | 0.00% | -33.3% |
| Q4 2019 | $286,000 | +102.8% | 86,559 | +25.7% | 0.00% | +200.0% |
| Q3 2019 | $141,000 | +252.5% | 68,842 | +545.1% | 0.00% | – |
| Q1 2019 | $40,000 | -2.4% | 10,672 | +0.9% | 0.00% | – |
| Q2 2018 | $41,000 | -60.2% | 10,575 | -34.7% | 0.00% | -100.0% |
| Q3 2017 | $103,000 | +25.6% | 16,194 | +54.2% | 0.00% | 0.0% |
| Q2 2017 | $82,000 | -53.9% | 10,504 | -45.0% | 0.00% | -50.0% |
| Q3 2016 | $178,000 | +87.4% | 19,083 | +75.4% | 0.00% | +100.0% |
| Q1 2016 | $95,000 | -29.1% | 10,879 | -25.7% | 0.00% | 0.0% |
| Q4 2014 | $134,000 | -7.6% | 14,644 | +9.1% | 0.00% | 0.0% |
| Q2 2014 | $145,000 | – | 13,419 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Round Table Services, LLC | 129,500 | $1,207,000 | 0.72% |
| STONERIDGE INVESTMENT PARTNERS LLC | 252,376 | $2,352,000 | 0.34% |
| Bellevue Group AG | 155,000 | $1,445,000 | 0.26% |
| WASATCH ADVISORS LP | 1,861,553 | $17,350,000 | 0.26% |
| Blue Clay Capital Management, LLC | 13,000 | $121,000 | 0.14% |
| Virtus ETF Advisers LLC | 24,058 | $224,000 | 0.11% |
| EMERALD ADVISERS, LLC | 203,737 | $1,899,000 | 0.08% |
| Vident Investment Advisory, LLC | 63,383 | $591,000 | 0.08% |
| Thomas J. Herzfeld Advisors, Inc. | 15,000 | $140,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 94,400 | $880,000 | 0.05% |